{
  "main_header": {
    "sid": 525226,
    "name": "Indrayani Biotec",
    "stock_name": "Indrayani Biotec",
    "full_name": "Indrayani Biotech Ltd",
    "name_url": "stocks-analysis/indrayani-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "11.00",
    "chg": -0.08,
    "chgp": "-0.72%",
    "dir": -1,
    "prev_price": "11.08",
    "mcapval": "85.87 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526445,
    "symbol": "",
    "ind_name": "Other Agricultural Products",
    "ind_code": 101,
    "indexname": "India SENSEX",
    "isin": "INE007C01021",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "17.98 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/indrayani-biotec-525226-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indrayani Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indrayani-biotech-ltd-is-rated-strong-sell-3937361",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndrayaniBiotec_mojoScore_3937361.png",
        "date": "2026-04-08 10:10:35",
        "description": "Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      }
    ],
    "total": 9,
    "sid": "525226",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/indrayani-biotech-525226"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "03-Jun-2026",
      "details": "Resignation of Mrs. Ramya Ravi as the Company Secretary and Compliance Officer of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30",
      "datetime": "27-May-2026",
      "details": "Resignation letter of Mr. Indirakumar",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) - Outcome Of The Rights Issue Committee Meeting Held On 25Th May 2026",
      "datetime": "25-May-2026",
      "details": "Outcome of the Rights Issue Committee Meeting held on 25th May 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Indrayani Biotech Ltd has announced <strong>5:7</strong> rights issue, ex-date: 28 Apr 26",
          "dt": "2026-04-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Indrayani Biotech Ltd is Rated Strong Sell

2026-04-08 10:10:35

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read More

View All News